A study on subjects with pulmonary arterial hypertension (PAH) in China suggests that −572C/G promoter polymorphism in the interleukin-6 (IL-6) gene is associated with serum IL-6 levels and risk of hypertension [78]. The gene discussed is IL6; the disease is pulmonary arterial hypertension.